Article metrics

Download PDFPDF

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

 

Online download statistics by month:

Online download statistics by month: June 2020 to July 2022

AbstractFullPdf
Jun 2020335335167
Jul 202015615648
Aug 2020596038
Sep 2020616131
Oct 2020808063
Nov 2020353516
Dec 2020505017
Jan 2021797921
Feb 2021616111
Mar 202112312330
Apr 2021848438
May 2021676728
Jun 2021848441
Jul 2021747435
Aug 2021707037
Sep 2021979733
Oct 2021595940
Nov 2021737447
Dec 2021717226
Jan 2022767720
Feb 2022434316
Mar 202211912936
Apr 202221121535
May 202219119540
Jun 202216016231
Jul 202217817923
Total26962721968